Stay up to date with

Dear Reader,

Your dosage of information: Our Pharma & Food newsletter gathers the latest trends, regulations and developments from the international pharmaceutical and F&B markets. From laboratory development to sterile packaging, we provide you with the facts and best practices to give your pharma and food process the competitive edge.
You can personalise your newsletter via ‘My Site’ on

Best wishes,
Your team of

Japan/USA: Takeover Flurry in Pharmaceuticals
Shire Turns Down 60 Billion Dollar Takeover Bid from Takeda
Shire announced that it has turned down repeated takeover offers from Takeda Pharmaceutical. The latest offer amounted to about $ 60 billion. According to the company, the two sides were in talks about another “more attractive” transaction. more
Biomimetic Chemistry
Tricking Viral Enzymes into Binding with Synthetic DNA
Synthetic molecules can not only mimic the structures of their biological models, they can also take on their functions and may even successfully compete with them, as an artificial DNA sequence designed by LMU chemist Ivan Huc now shows. more
USA/Germany: Healthcare Business
P&G Acquires Merck‘s Consumer-Health Business for 4.2 Billion Dollars
Procter & Gamble agreed to buy Merck’s consumer-health business for $ 4.2 billion to bolster growth, betting that vitamins and decongestants can hasten its comeback. German drugmaker Merck put the the unit up for sale last year as it pumps money into testing new medicines. more
USA: Biotech Collaboration
Sartorius Stedim Biotech Partners with Penn State University for Research in Biotechnology
Through this collaboration, the German-based company intends to create a biotechnology hub that promotes innovation. more
France: Biotechnology
Sanofi to Sell European Generic-Drug Unit to Advent
Sanofi plans to sell its European generic-drug unit to buyout firm Advent International for $ 2.4 billion as part of a broader move by Chief Executive Officer Olivier Brandicourt to focus resources on biotechnology and new medicines. more
The Netherlands: Biopharma Expansion
Wacker Expands Pharmaceutical-Protein Business by Acquiring Synco’s Plant
Synco specialises in manufacturing live microbial biopharmaceuticals and the takeover is a vital move for Wacker to maintain its position in the highly competitive biopharmaceuticals market. more
France: Pharmaceutical Industry
Advent Close to Acquiring Sanofi‘s European Generics Division
Advent International is apparently close to acquiring Sanofi’s European generics division in a deal valued at about $ 2.5 billion including debt. more
Vogel Logo   Facebook Logo    Twitter Logo   
Declaration of Consent   Contact    Media


Vogel Business Media GmbH & Co.KG - Editorial Office PROCESS - Max-Planck-Str. 7/9, 97082 Wuerzburg, Germany - Phone: +49 931 418-0 
Register Court Wuerzburg, HRA 5385 - VAT Identification Number: DE 231711381 - General Partner: Vogel Industrie Medien Verwaltungs GmbH, Wuerzburg Register Court HRB 8146  - Publisher: Gerd Kielburger (responsible for content print/online)  - Online Editor: Matthias Back, Dominik Stephan

If there are any problems regarding the display of this mail, please click here
The newsletter is addressed to unknown@unknown.invalid